BharatH.BaraiMD

Oncology • Merrillville, IN

Breast Cancer, Gastrointestinal Cancer, Hematologic Oncology, Thoracic Cancer

Clin Asst Professor of Medicine, Indiana University Medical School

Join to view full profile

Dr. Barai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Barai's full profile

Already have an account?

Office
200 E 89th Ave
Suite 2a
Merrillville, IN 46410
Phone+1 219-736-2800

Fax+1 219-736-6680

Education & Training

Rush University Medical CenterFellowship, Hematology and Medical Oncology, 1979 - 1980
Northwestern Memorial Hospital1977 - 1979
Advocate Health Care/Advocate Illinois Masonic Medical CenterResidency, Internal Medicine, 1975 - 1977
Baroda Medical CollegeClass of 1971

Certifications & Licensure

IN State Medical License 1980 - 2025
IL State Medical License 1976 - 1987
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
Completed
Phase 3
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
Active, not recruiting
Phase 3
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Completed
Phase 3
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Start of enrollment: 2009 Jul 15
Terminated
Phase 3
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Start of enrollment: 2010 Oct 25
Completed
Phase 3
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Start of enrollment: 2011 Apr 01
Active, not recruiting
Phase 3
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy Start of enrollment: 2010 Sep 15
Terminated
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
S0820, Adenoma and Second Primary Prevention Trial Start of enrollment: 2013 Aug 23
Active, not recruiting
Phase 3
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma Start of enrollment: 2013 Aug 27
Active, not recruiting
Phase 2
Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry Start of enrollment: 2015 Nov 01
Completed
Join now to see all

Press Mentions

Hyderabad-Based Biological E Partners with J&J for Vaccine ManufacturingMay 19th, 2021
Hydroxychloroquine Given Under Supervision, Side Effects Can Be Addressed: Indian-American DoctorMay 26th, 2020
Hollywood Celebs to Join Indian American Physicians’ Annual Meet in ChicagoFebruary 6th, 2020

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
American Society of Hematology - ASH
Member
American Medical Association - AMA
Member